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Abstract: 24 
Background:  25 
Dwarfism is associated with skeletal dysplasias and joint deformities that frequently 26 
result in osteoarthritis requiring treatment with total knee arthroplasty (TKA). These surgeries 27 
can be challenging due to alignment deformities, poor bone stock, and smaller components. This 28 
study aims to compare TKA implant survivorship and complications between dwarf and non-29 
dwarf patients. 30 
 31 
Methods: 32 
A retrospective case-control study was performed from 1997-2014 evaluating 115 TKAs 33 
in patients under the height threshold of 147.32cm. This cohort was compared to 164 patients of 34 
normal height, using propensity score weighting to balance gender, age, year of surgery, and 35 
comorbidities. Medical records were reviewed for demographics, surgical characteristics, and 36 
outcomes. Radiographic evaluation was performed to assess alignment, periprosthetic fractures, 37 
and loosening. All cases had 2-year minimum follow-up. 38 
 39 
Results: 40 
The revision rate was 8.7% in dwarfs compared with 3.7% in controls (p=0.08). The 2-, 41 
5-, and 10-year implant survivorship in dwarfs was 96.4%, 92.5%, and 90.2%, respectively; and 42 
96.6%, 95.6%, and 94.8% for controls, respectively (p=0.24). Dwarfs underwent significantly 43 
more manipulations for arthrofibrosis (p=0.002). There was greater femoral (17.4% vs. 2.1%, 44 
p<0.01) and tibial (6.5% vs 2.7%, p<0.01) component overhang in dwarfs compared to controls. 45 
 46 
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Conclusions: 47 
Despite a two-fold increase in the revision rate of the dwarf cohort, the midterm 48 
survivorship is comparable between the dwarf and non-dwarf patients. However, dwarfs were 49 
more likely to become stiff and undergo manipulation; the increased propensity for stiffness may 50 
be associated with oversized components, as evidenced by greater component overhang, and an 51 
increased incidence of spinal pathology which has also been shown to lead to post-operative 52 
stiffness. Surgeons should be aware of this increased risk and may consider using smaller or 53 
customized implants to account for the morphological differences in this patient population. 54 
 55 
Keywords: dwarf; total knee arthroplasty; outcomes; survivorship; complications 56 
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Introduction 73 
 74 
Dwarfism can be a result of over 200 conditions, including endocrine disorders such as 75 
pituitary dwarfism and hypothyroidism, systemic disorders causing growth failure, genetic 76 
diseases, and skeletal dysplasias. Additionally, it is not uncommon for patients to be of 77 
idiopathic short stature, which is a height less than 147.32 cm according to the legal 78 
definition.[1] The most common form of genetic dwarfism, achondroplasia, accounts for 70% of 79 
all dwarfism and affects 1 in 15,000 to 1 in 40,000 people.[2] Among this population, skeletal 80 
dysplasias, such as achondroplasia, result in atypical load distribution in weight-bearing joints 81 
and can lead to orthopaedic complications such as joint deformity, particularly genu valgum; 82 
ligamentous laxity; and early degenerative joint disease.[3,4] As a result, these patients will often 83 
present as candidates for total knee arthroplasty (TKA).  84 
Orthopaedic surgeons face several challenges when performing TKA in this population. 85 
Smaller components may be necessary, severe alignment deformities can be encountered, poor 86 
bone stock and soft tissue laxity or contractures may be present[5,6]. Despite these challenges, 87 
however, the body of literature regarding the clinical outcomes and complications of TKA in the 88 
dwarf population is not extensive. While many previous studies highlight a variety of potential 89 
intraoperative and postoperative complications, they are frequently of limited size due to the 90 
relative rarity of dwarfism.[5,7] Furthermore, a control group is often not present to serve as a 91 
comparative reference. Thus, the purpose of this study is to compare the revision rates and 92 
implant survivorship between dwarf and non-dwarf patients undergoing TKA. 93 
 94 
Methods 95 
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A retrospective case-control study was performed between 1997 and 2014 on primary 96 
TKA patients under the height threshold of 147.32 cm (4’10”) using our institutional database. 97 
With these criteria, we identified 157 cases of primary TKA (156 females and 1 male). The 98 
average height was 146.43 cm and the mean age at the time of surgery was 70.7±10.7 years. We 99 
included all patients with a minimum 2-year follow-up (mean 6.2years, range 2.0-17.2), which 100 
left us with 115 TKAs in our final cohort. The primary etiology for TKA was osteoarthritis 101 
(112/115).  102 
To obtain a balanced comparison with a control group of 164 patients with greater than 103 
143.32 cm height, propensity score weighting was used to control for age, gender, Charlson 104 
comorbidity index[8], and year of surgery. The weights were generated using logistic regression 105 
to estimate the probability of being a dwarf based on the other variables, and then the weight was 106 
set to 1/prob[patient is dwarf] for patients who were dwarves, and 1/[1-prob[dwarf]] for non-107 
dwarf patients.  The weights were then normalized to a mean of 1.0. The weights ranged from 108 
0.50 – 3.11; there were no extreme weights due to probabilities near 0 or near 1.  Table 1 109 
provides the demographics of the patient populations. All TKAs were done using posterior 110 
stabilized knees from three manufacturers (Zimmer [Warsaw, Indiana], Stryker [Mahwah, NJ], 111 
Depuy [Warsaw, Indiana]).  112 
 A manual review of the medical record was performed to identify patient demographics, 113 
surgical and hospital characteristics (operative time), and outcomes. The evaluated outcomes 114 
included any revision surgery and the reason for revision, subsequent procedures including 115 
manipulations under anesthesia, and intraoperative and postoperative complications, such as 116 
periprosthetic fracture, aseptic loosening, polyethylene wear/osteolysis, periprosthetic joint 117 
infection (PJI) defined by the International Consensus Meeting definition,[9] and dislocations.  118 
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 119 
Radiographic Analysis 120 
Serial radiographic evaluation was performed of all anteroposterior and lateral 121 
radiographs by two independent orthopaedic surgeons on all preoperative, postoperative, and 122 
follow-up films. The inter-rater reliability (as measured by the concordance correlation 123 
coefficient) between the two orthopaedic surgeons was 0.94 (95% confidence interval [CI]: 0.91-124 
0.96). Follow-up radiographs were also analyzed for radiolucent lines, periprosthetic fractures, 125 
and femoral and tibial component overhang. All measurements were obtained using digital 126 
imaging software, PACS (National Institutes of Health, Bethesda, MD) to obtain anatomic axis. 127 
Anatomic axis was measured using the angle formed by a line drawn from the center of the knee 128 
joint to the most proximal point of the mid-diaphyseal femur and a line drawn from the center of 129 
the knee joint to the most distal point of the mid-diaphyseal tibia. Normal femorotibial angles 130 
range from 174° to 178° depending on gender and race. While the tibial mechanical and 131 
anatomic axes are aligned, the femoral anatomical axis can be inclined 5-7° more than the 132 
mechanical axis. Further variation can result from tibial and femoral deformities and variation in 133 
hip angle. Cherian et al. discuss in greater detail the general principles behind radiographic axes 134 
and their application in TKA.[10] Radiographic loosening was defined by the presence or 135 
progression of component migration, change in position, subsidence, and complete radiolucent 136 
lines greater than 1mm[11]. Tibial component overhang was defined as any prosthetic material 137 
occurring outside the boundaries of a vertical line that extending from the cortex of the proximal 138 
part of the tibial plateau[12]. In contrast, femoral overhang was defined as component overhang 139 
>2mm in any of the 5 zones defined by the Knee Society[11,13]. 140 
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 141 
Statistical Analysis 142 
All statistical analyses were performed with R software 3.3.2 (R Foundation for 143 
Statistical Computing, Vienna, Austria) using an alpha level of 0.05 to determine significance. 144 
Kaplan-Meier survivorship curves were generated for 2-, 5-, and 10-year follow-up. Differences 145 
in survivorship were assessed using the log-rank test, while a Fisher’s exact test was used to 146 
evaluate differences in revision rates. Student’s t-tests were used to compare means between x-147 
ray radiographic measurements. Our primary endpoint was the survivorship of the prosthesis or 148 
revision surgery for any reason. Secondary endpoints such as operative time, rate of 149 
manipulation procedures, and any significant radiographic differences between the groups were 150 
considered. 151 
 152 
Results 153 
Using propensity score weighting, the 5-, and 10-year survivorship was 92.5% (95% 154 
CI:87.8% -97.6%), and 90.2% (95% CI: 83.9% - 96.9%), respectively, for the dwarf cohort; and 155 
95.6% (95% CI: 92.1% - 99.3% ), and 94.8% (95% CI: 90.6% - 99.2%) for the non-dwarf 156 
cohort, respectively. The results were almost identical without the weighting.  Overall, there was 157 
no difference in survivorship between the dwarf and non-dwarf cohorts (p=0.24, Figures 1 and 158 
2). The revision surgery rate was 8.7% in the dwarf cohort compared with 3.7% in the control 159 
group. There was no statistically significant difference in the overall rate of revision (odds ratio 160 
[OR] 2.51, p=0.08), but the operative time was longer for dwarfs compared to controls (84.4 vs 161 
74.6 min; p=0.01). 162 
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The reasons for revision in the dwarf group included aseptic loosening (n=3), PJI (n=3), 163 
patellofemoral arthritis (n=1), cement extrusion with pain (n=1), and periprosthetic fractures 164 
(n=2) (Table 2). Periprosthetic fractures were postoperative and included one tibial plateau 165 
fracture that had healed but required subsequent exchange of the tibial component, and one 166 
femur fracture that was treated with open reduction and internal fixation. However, the dwarf 167 
cohort underwent significantly more manipulations for arthrofibrosis (6.1% vs 0.0%, p=0.002). 168 
In the 7 patients that underwent manipulations under anesthesia, 29% (2/7) had femoral 169 
component overhang. In contrast, 18.5% (20/108) of TKAs that did not undergo manipulation 170 
had femoral component overhang. 171 
In the control group, the pre- and post-operative anatomical axis values were 178.6º±6.5 172 
and 175.9º±2.9, respectively. The pre- and post-operative anatomical axes in the dwarf group 173 
were 178.7º±8.7º and 176.3º±3.0º, respectively. There was no difference in pre-operative 174 
deformity between the dwarf and control cohorts (p=0.97), and there was no significant 175 
difference in postoperative alignment (p=0.62). However, there was greater femoral component 176 
overhang in the dwarf cohort (17.4%) compared to the control cohort (2.1%, OR 9.65, 95%CI: 177 
5.40-17.27, p<0.01), and more tibial component overhang (6.5%) in dwarf patients compared to 178 
the control group (2.7%, OR 2.47, 95% CI: 1.36-4.49, p<0.01). For patients with tibial overhang, 179 
there was a trend towards a higher amount of tibial overhang in dwarfs (2.36 mm) compared to 180 
control patients (1.81 mm, p=0.09) (Table 3). 181 
 182 
Discussion 183 
While previous studies have shown that TKA is an effective treatment for degenerative 184 
disease in the joints of dwarfs, the literature regarding this unique and challenging population is 185 
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limited. Orthopaedic surgeons must be cognizant that these patients may have poor bone stock, 186 
severe deformity necessitating soft tissue releases, and may require the use of smaller implants 187 
which can compromise surgery.  188 
The results of the present study suggest that TKA in dwarfs demonstrate similar implant 189 
survivorship compared with a matched control cohort; however, surgeons should be aware that 190 
an increased rate of complications was found, although not statistically significant. TKA patients 191 
with dwarfism experienced greater post-operative stiffness resulting in a higher risk for 192 
manipulations, with approximately 1 in 20 dwarfs undergoing manipulation compared to none in 193 
the control cohort. This may be reflective of suboptimal component sizing, as component 194 
overhang was greater in the dwarf cohort. Also, since spine disease can lead to increased post-195 
operative stiffness and manipulations, the increased incidence of spine pathology in dwarfs could 196 
also be a reason for the higher incidence of dwarf manipulations in this study. While dwarf 197 
patients were not predisposed to increased risk of malalignment compared with non-dwarfs, 198 
there was an association between dwarfism and longer operative times. 199 
Questions have been raised about whether short stature can be indicative of poorer 200 
prosthesis survivorship and increased rates of complications.[5,6] Although prior studies have 201 
demonstrated that there are many benefits of the procedure, including functional outcome 202 
improvement,[7,14–19] they have not firmly established whether the results are comparable to 203 
those of normal stature. The use of a control group in our study allowed us to account for factors 204 
such as age, other relevant medical conditions (comorbidity index), and year of surgery for 205 
patients of normal stature. Although the older cases included may have used different surgical 206 
and anesthetic techniques with intrinsically higher risk for complication, it was our hope that 207 
controlling for year of surgery would help account for some of the temporal advancements in 208 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
10 
 
surgical technique and safety. In our study, TKAs performed in dwarfs demonstrated similar 209 
survivorship to that of the matched cohort. This is in contrast to Guenther et al., who found 210 
decreased 5 year survivorship in a case series of 138 TKAs in spite of overall improved 211 
functional outcome and International Knee Society (IKS) scores.[6] Although there were no 212 
statistically significant differences in revision rates in our study, our results indicate a 213 
significantly higher need for knee manipulations after TKA due to stiffness in dwarfs. While it 214 
has been argued that standard prostheses along with diligent preoperative planning can result in 215 
equally positive functional outcomes,[16] our results may demonstrate the contrary 216 
radiographically. Since many dwarf patients in our cohort had components that demonstrated 217 
overhang, the increased propensity for stiffness may be associated with oversized components; 218 
anterolateral overhang affects sagittal balance while mediolateral overhang can place excessive 219 
strain on the collaterals resulting in limited joint flexion motion[20,21]. Component overhang 220 
was greater for the femur, and there was a larger average distance of overhang of the tibial 221 
component in dwarf patients. Thus, ensuring proper component sizing for this population is 222 
critical and different implants may need to be used to accommodate this. Measures to prevent 223 
oversizing include using preoperative computed tomography, making femoral cuts by hand, or 224 
even utilizing custom-designed implants when appropriate to circumvent this 225 
complication.[5,7,19] 226 
Our study had a number of limitations, and our findings should be interpreted in light of 227 
these issues. This study was retrospective, so we were limited to the data already available in the 228 
system, particularly lateral radiographs. In addition, long alignment x-rays were not available for 229 
most of these patients to measure anatomical and mechanical axes; thus, our measurements of 230 
anatomical axes may have been affected. In addition, a longer-term follow-up period on all the 231 
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patients may have demonstrated some otherwise unseen results in the rates of revision, which has 232 
been demonstrated in the literature.[14,15] Furthermore, it was difficult to accurately determine 233 
the etiology of short stature in each individual, especially since it was poorly documented in the 234 
medical record or never diagnosed despite skeletal dysplasia. It is suspected that some of the 235 
patients naturally had short stature, as there was a significant presence of elderly females in our 236 
dwarf patient population. Due to low number of patients within the various etiologies for 237 
dwarfism, we could not analyze clinical outcomes stratified by diagnosis and thus could not 238 
differentiate how TKA might be affected in different subsets of skeletal dysplasia. However, this 239 
population still faces similar challenges to that of the dwarf population, as component sizing and 240 
poor bone quality must be taken into account. Lastly, we did not assess the functional outcome 241 
scores of our patients before and after the procedure. However, a recent study by Guenther et al. 242 
demonstrated that functional outcomes were significantly improved at 1 (67, p<0.001) and 5 year 243 
(65, p<0.001) postoperatively from admission (35). Although it has been established that 244 
postoperative knee function in dwarfs is significantly improved, it would have been interesting to 245 
see if the level of improvement is greater than or less than that of normal-height patients.  246 
This study demonstrates that dwarfs undergoing TKA demonstrate no difference in 247 
midterm survivorship. However, patients with dwarfism were more likely to become stiff and 248 
may undergo manipulation. Surgeons should be aware of this increased risk and should ensure 249 
appropriate sizing with their surgical planning and technique. Further investigation should be 250 
performed to assess whether or not these general findings translate to specific conditions that can 251 
contribute to dwarfism and short stature.  252 
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Table 1. Demographics of the patient population 
 
 Sample 
size 
Age Gender BMI Charlson 
score 
Follow-up 
(years) 
TKA 
Dwarfs 
115 70.2±10.8 115 females 
(100%) 
31.2±7.3 4.0±1.4 6.2±3.6  
TKA 
Controls 
164 66.5±10.0 160 female 
(97.6%), 4 
male (2.4%) 
32.4±6.5 3.4±1.3 5.5±2.6 
TKA=total knee arthroplasty; BMI=body mass index 
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Table 2. Total knee arthroplasty revisions in dwarfs and controls, with most common reasons for 
revision. 
 Revision 
Rate 
(%) 
Periprosthetic 
joint infection 
(n) 
Aseptic 
Loosening 
(n) 
Periprosthetic 
Fracture (n) 
Other (n) 
Dwarfs 8.7% 
(10/115) 
3 3 2 2 (patellofemoral arthritis, 
cement extrusion with pain) 
Controls 3.7% 
(6/164) 
4 2 0 0 
Odds 
Ratio 
2.51 1.07 2.17 7.25 - 
P-value 0.08 0.93 0.40 0.20 - 
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Table 3. Total knee arthroplasty x-ray measurements in dwarfs and controls. 1 
 Dwarfs Controls P-value 
Pre-operative Anatomic 
Axis (mean ±standard 
deviation) 
178.7º±8.7º 178.6º±6.5º 0.97 
Post-operative Anatomic 
Axis (mean ±standard 
deviation) 
176.3º±3.0º 175.9º±2.9º 0.62 
Tibial component 
overhang  
(mean ±standard 
deviation) 
2.36mm±1.52 1.81mm±0.63 0.09 
Tibial component 
overhang (%) 
6.5% 2.7% <0.01 
Femoral component 
overhang (%) 
17.4% 2.1% <0.01 
 2 
 3 
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Figure Legends: 1 
Figure 1. Survivorship curve for patients undergoing primary total knee arthroplasty using 2 
propensity score weighting. 3 
 4 
Figure 2. Survivorship curve for patients undergoing primary total knee arthroplasty without 5 
propensity score weighting. 6 
 7 
